McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed May 3, 2018
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Award
Common Stock
2018-05-01+16,000→ 16,000 total - Award
Employee Stock Option (Right to Buy)
2018-05-01+110,000→ 110,000 totalExercise: $28.30Exp: 2028-04-30→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in four (4) equal annual installments beginning from June 15, 2018, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the "Plan")) on each vesting date.
- [F2]The shares subject to the stock option shall vest over a period of four years commencing on May 1, 2018, with 25% vesting on the first anniversary of the vesting commencement date and 1/48th vesting each month thereafter over the remaining three years, subject to Ms. McDowell's Continuous Service (as defined in the Plan) through each such vesting date.